Complications and Outcomes of Endoscopic Treatment in a Cohort of Patients With Biliary Stenosis After Orthotopic Liver Transplant: A Retrospective Observational Study

2019 ◽  
Vol 17 (4) ◽  
pp. 513-521
Author(s):  
Luca Bortolasi ◽  
Paola Violi ◽  
Amedeo Carraro ◽  
Umberto Montin ◽  
Angelo Cerofolini ◽  
...  
Keyword(s):  
Observational Study ◽  
Liver Transplant ◽  
Endoscopic Treatment ◽  
Orthotopic Liver Transplant ◽  
Retrospective Observational Study ◽  
Biliary Stenosis

scholarly journals Acute kidney injury and chronic kidney disease after liver transplant: A retrospective observational study

Nefrología ◽  
2021 ◽  
Author(s):  
Fabrizio Fabrizi ◽  
Maria F. Donato ◽  
Roberta Cerutti ◽  
Federica Invernizzi ◽  
Giulia Porata ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Acute Kidney Injury ◽  
Kidney Disease ◽  
Observational Study ◽  
Liver Transplant ◽  
Kidney Injury ◽  
Retrospective Observational Study

Sa1471 CAN WE PREDICT ENDOSCOPIC TREATMENT OUTCOME OF BILIARY ANASTOMOTIC STRICTURE AFTER ORTHOTOPIC LIVER TRANSPLANT?

2019 ◽  
Vol 89 (6) ◽  
pp. AB247
Author(s):  
Fernanda P. Martins ◽  
Silvia M. Reimão ◽  
Gustavo A. de Paulo ◽  
Monica Contini ◽  
Angelo P. Ferrari
Keyword(s):  
Treatment Outcome ◽  
Liver Transplant ◽  
Endoscopic Treatment ◽  
Anastomotic Stricture ◽  
Orthotopic Liver Transplant

Hemmkörperentwicklung bei Hämophilie-Patienten nach Präparate wechsel

2012 ◽  
Vol 32 (S 01) ◽  
pp. S39-S42 ◽  
Author(s):  
S. Kocher ◽  
G. Asmelash ◽  
V. Makki ◽  
S. Müller ◽  
S. Krekeler ◽  
...  
Keyword(s):  
Risk Factors ◽  
Risk Factor ◽  
Observational Study ◽  
Retrospective Observational Study ◽  
Frequent Change ◽  
Patient Age ◽  
Treatment Regimens ◽  
Patient Âgé ◽  
The Relationship ◽  
Observation Period

SummaryThe retrospective observational study surveys the relationship between development of inhibitors in the treatment of haemophilia patients and risk factors such as changing FVIII products. A total of 119 patients were included in this study, 198 changes of FVIII products were evaluated. Results: During the observation period of 12 months none of the patients developed an inhibitor, which was temporally associated with a change of FVIII products. A frequent change of FVIII products didn’t lead to an increase in inhibitor risk. The change between plasmatic and recombinant preparations could not be confirmed as a risk factor. Furthermore, no correlation between treatment regimens, severity, patient age and comorbidities of the patients could be found.

Sign in / Sign up

Export Citation Format

Share Document